Green Thumb Industries (OTCMKTS:GTBIF) Issues Quarterly Earnings Results

Green Thumb Industries (OTCMKTS:GTBIF) posted its quarterly earnings results on Wednesday. The company reported $0.04 earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02), Zacks reports. Green Thumb Industries had a return on equity of 3.39% and a net margin of 5.38%. The business had revenue of $294.32 million for the quarter, compared to analyst estimates of $289.66 million.

Green Thumb Industries Trading Up 3.2 %

GTBIF stock opened at $7.20 on Friday. The firm has a market cap of $1.53 billion, a PE ratio of 30.00 and a beta of 1.32. The stock has a 50-day moving average price of $7.36 and a 200-day moving average price of $8.99. Green Thumb Industries has a 1-year low of $6.60 and a 1-year high of $16.33.

Wall Street Analysts Forecast Growth

Separately, Roth Capital raised Green Thumb Industries to a “strong-buy” rating in a report on Sunday, November 10th. Two equities research analysts have rated the stock with a buy rating and three have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Strong Buy” and an average target price of $16.50.

Green Thumb Industries Company Profile

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.